sellWeak10b5-1 plan
Hope Stephen W. sold $655k of ADSK
SVP & Chief Accounting Officer at Autodesk, Inc.. 2,452 shares at an average of $267.29, traded Mar 28, 2025, filed Mar 28, 2025.
Warning score
25Value
$655k
2,452 shares
Holdings after
3,003
-45% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000769397-25-000033, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 27, 2025 | FTax withholding Common Stock10b5-1 | -671 | $271.21 | $182k | 4,208 | Mar 28, 2025 |
| Mar 27, 2025 | AGrant or award Common Stock10b5-1 | +1,936 | $0.00 | $0 | 6,144 | Mar 28, 2025 |
| Mar 27, 2025 | FTax withholding Common Stock10b5-1 | -689 | $271.21 | $187k | 5,455 | Mar 28, 2025 |
| Mar 28, 2025 | SOpen-market sale Common Stock10b5-1 | -2,452 | $267.29 | $655k | 3,003 | Mar 28, 2025 |
Related signals
Other insiders at Autodesk, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 41Moderate | buy | ADSK Autodesk, Inc. | CAHILL JOHN T director | $534k | 2,000 | |
| 19Weak | sell10b5-1 | ADSK Autodesk, Inc. | NORRINGTON LORRIE M director | $543k | 1,778 | |
| 19Weak | sell10b5-1 | ADSK Autodesk, Inc. | NORRINGTON LORRIE M director | $544k | 1,778 | |
| 6Weak | sell10b5-1 | ADSK Autodesk, Inc. | MCDOWELL MARY T director | $168k | 550 | |
| 14Weak | sell 210b5-1 | ADSK Autodesk, Inc. | MCDOWELL MARY T director | $157k | 550 | |
| 3Weak | sell 210b5-1 | ADSK Autodesk, Inc. | Hope Stephen W. SVP & Chief Accounting Officer | $15k | 54 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.